Pharmacist intervention program for control of hypertension

Annals of Pharmacotherapy

Volumn 37, Issue 9, 2003, Pages 1186-1193

  Chabot, Isabelle ^a   Moisan, Jocelyne ^b,c   Grégoire, Jean Pierre ^a,b,c   Milot, Alain ^b,c  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adherence; Hypertension; Pharmaceutical care; Socioeconomic status

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ALGORITHM; ARTICLE; BLOOD PRESSURE REGULATION; COMPARATIVE STUDY; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; HEALTH PROGRAM; HUMAN; HYPERTENSION; INCOME; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACIST; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF REPORT; SOCIOECONOMICS; TREATMENT OUTCOME; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; HYPERTENSION; LIFE STYLE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACISTS; PROFESSIONAL ROLE; QUESTIONNAIRES;

EID: 0042631526     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C267     Document Type: Article

References (25)

1. Joffres MR, Hamet P, MacLean DR, L'Italien GJ, Fodor G. Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens 2001;14(11 pt 1):1099-105.
2. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46.
3. Berlowitz DR, Ash AS, Hickey EC, Friedman RH, Glickman M, Kader B, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63.
4. Park JJ, Kelly P, Carter BL, Burgess PP. Comprehensive pharmaceutical care in the chain setting, J Am Pharm Assoc (Wash) 1996;NS36:443-51.
5. Carter BL, Barnette DJ, Chrischilles E, Mazzotti GJ, Asali ZJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997;17:1274-85.
6. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy 1997;17:140-7.
7. Bogden PE, Abbott RD, Williamson P, Onopa JK, Koontz LM. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med 1998;13:740-5.
8. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20:1384-9.
9. Okamoto MP, Nakahiro RK. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Pharmacotherapy 2001;21:1337-44.
10. Green LW, Kreuter MW, Bull J, eds. Health promotion planning: an educational and environmental approach. 2nd ed. Mountain View, CA: Mayfield Publishing, 1991.
11. Reeves RA, Fodor JG, Gryfe CI, Patterson C, Spence JD. Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. CMAJ 1993;149:815-20.
12. Frohlich ED, Grim C, Labarthe DR, Maxwell MH, Perloff D, Weidman WH. Recommendations for human blood pressure determination by sphygmomanometers. Hypertension 1988;11(suppl):209A-22A.
13. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24: 67-74.
14. Grégoire JP, Guibert R, Archambault A, Contandriopoulos A-P. Medication compliance in a family practice. Can Family Physician 1992;38: 2333-7.
15. Feldman RD, Campbell N, Larochelle P, Bolli P, Burgess ED, Carruthers SG, et al. 1999 Canadian recommendations for the management of hypertension. CMAJ 1999:161(suppl):S1-22.
16. Izzo JL Jr, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension 2000;35:1021-4.
17. Guidelines Subcommittee. 1999 World Health Organisation - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
18. Willey C. Behavior-changing methods for improving adherence to medication. Curr Hypertens Rep 1999;1:477-81.
19. Ben-Sira Z. Eclectic incentives for health protective behavior: an additional perspective on health oriented behavior change. Health Educ Res 1991;6:211-29.
20. Atkins CJ, Senn K, Rupp J, Kaplan RM, Patterson TL, Sallis JFJ, et al. Attendance at health promotion programs: baseline predictors and program outcomes. Health Educ Q 1990;17:417-28.
21. Adler NE, Boyce T, Chesney MA, Cohen S, Folkman S, Kahn RL, et al. Socioeconomic status and health. The challenge of the gradient. Am Psychol 1994;49:15-24.
22. Pincus T, Esther R, DeWalt DA, Callahan LF. Social conditions and self-management are more powerful determinants of health than access to care. Arch Intern Med 1998;129:406-11.
23. Sheal S, Stein AD, Basch CE, Lantigua R, Maylahn C, Strogatz DS, et al. Independent associations of educational attainment and ethnicity with behavioral factors for cardiovascular disease. Am J Epidemiol 1991;134: 567-82.
24. Cockerham WC, Lueschen G, Kunz G, Spaeth JL. Social stratification and self-management of health. J Health Soc Behav 1986;27:1-14.
25. Rossi P, Freeman H. Evaluation. 5th ed. Newbury Park, CA: Sage Publications, 1993.